Evidence map›Paper›PMID 42297567›Full record

ArticleChemMedChem2026

Total Synthesis and Antimalarial Studies of Caelestines A-C.

Henry S T Smith, Aaron M Lock, Vicky M Avery, Rohan A Davis

Abstract read
In one paragraph

Article in ChemMedChem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Henry S T SmithInstitute for Biomedicine and Glycomics, Griffith University, Nathan, Queensland, Australia.
Aaron M LockSchool of Environment and Science, Griffith University, Nathan, Queensland, Australia.
Vicky M AverySchool of Environment and Science, Griffith University, Nathan, Queensland, Australia.
Rohan A DavisInstitute for Biomedicine and Glycomics, Griffith University, Nathan, Queensland, Australia.ORCID https://orcid.org/0000-0003-4291-7573

Funding

Australian Research Council LE0237908Australian Research Council LE0668477Australian Research Council LE140100119Australian Research Council LE230100128
6 · The paper itself

Abstract

Caelestines A-D are 2-carboxy-4-quinolones (2C4Qs) first isolated from the Australian ascidian Aplidium caelestis. The caelestines are brominated analogues of kynurenic acid and xanthurenic acid, and the only brominated 2C4Qs isolated from nature. A convenient methodology exists for the Conrad synthesis of 2C4Qs from substituted anilines and acetylene dicarboxylates cyclised in Eaton's reagent. This approach yields regioisomers from asymmetric anilines and is hampered by the absence of chromatographic methods for isolation of pure isomers. Here, we report de novo synthesis of caelestines A-C using this methodology, constituting the first reported syntheses of caelestines B and C, as well as the first reported synthesis of five other novel bromo-quinolones and three related intermediates. The first chromatographic separation of caelestine isomers yielded by Conrad synthesis is described, and structure-activity relationships of caelestines A-C (and related bromo-quinolones) against the Plasmodium falciparum 3D7 (chloroquine-sensitive) and Dd2 (chloroquine-resistant) strains are elucidated.

Indexed as

4-QuinolonesAntimalarialsPlasmodium falciparumAnimalsMolecular StructureParasitic Sensitivity TestsStructure-Activity Relationship4-QuinolonesAntimalarialsantimalarial natural productcaelestinequinolonestructure–activity relationshiptotal synthesis

Identifiers

PMID42297567
PMCPMC13268815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.